HighTower Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100
Closed -$268 3711
2023
Q4
$268 Buy
+100
New +$10.2K ﹤0.01% 3593
2021
Q1
Sell
-8
Closed -$1K 3104
2020
Q4
$1K Buy
+8
New +$714 ﹤0.01% 2574
2020
Q3
Sell
-800
Closed -$1K 2583
2020
Q2
$1K Buy
+800
New +$71.6K ﹤0.01% 2404

Other funds holding DXCM

HighTower Advisors's DXCM Position: Q1 2026 in Review

HighTower Advisors reduced its DexCom (DXCM) stake by 3% in Q1 2026, selling an estimated $253K and leaving 118,064 shares worth $7.41M. The position accounts for 0.01% of the portfolio, ranked #1009.

HighTower Advisors first reported a position in DXCM in Q4 2014 and has held it in 46 quarters since. The position peaked at $18.5M in Q4 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • HighTower Advisors held 118,064 shares of DexCom worth $7.41M as of Q1 2026.
  • HighTower Advisors sold 3,633 DexCom shares in Q1 2026, an estimated $253K.
  • DexCom made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #1009 holding.
  • HighTower Advisors first reported a position in DexCom in Q4 2014 and has held it in 46 quarters since.
  • HighTower Advisors's DexCom position peaked at $18.5M in Q4 2020.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.